Second Joint Working Conference: National Cancer Institute Chemotherapy Program. Working session report: clinical trials.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001792:Blood Platelets; D001932:Brain Neoplasms / Q000473:pathology; D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy; D003428:Cross Infection / Q000517:prevention & control; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006650:Histocompatibility Testing; D006801:Humans; D007962:Leukocytes; D008175:Lung Neoplasms / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy; D013223:Statistics as Topic; D065227:Transfusion Reaction
D000970:Antineoplastic Agents; D005472:Fluorouracil